Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New York for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New York only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New York (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Chad Bouchard (NPI 1831328053)

Field	Value
Entity Type	Individual
Organization	Chad Bouchard
Address	1220 New Scotland Rd Ste 201
City	Slingerlands
State	NY
ZIP	12159
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	July 9, 2009

Payer Source	Total Paid
Medicare	$3.1M
Medicaid	$0

Key Findings

This provider’s revenue is effectively single‑payer Medicare: lifetime Medicare revenue is $3.1M and there is no Medicaid billing on file. Absence of any Medicaid claims means the provider’s public-payor exposure is concentrated entirely in Medicare rather than split across both programs.

Revenue concentration is high: the precomputed top 3 Medicare codes (J0178, J2777, 67028) account for 74.4% of this provider’s total Medicare revenue. Those three codes are dominated by high-value intravitreal drug administration and the isolated intravitreal injection procedure, indicating a narrow set of revenue drivers.

The code mix is classic for a retina specialty focused on pharmacologic retinal therapies and high-throughput clinic care: J0178 (aflibercept) and J2777 (faricimab) are the two largest revenue contributors ($1.1M and $1M revenue respectively), and 67028 (intravitreal injection as a separate procedure) also appears in the top three. Additional drug codes (J2781, J2778, J9035) and implant codes (J7312) in the top 25 further confirm an intravitreal injection–centric practice model combined with in‑clinic imaging and follow up.

Competitive standing across leading codes is mixed: J0178 (1.5K claims, $1.1M revenue) ranks #806 of 3204 providers nationally (75th percentile; typical, unremarkable volume for this code), while J2777 (36.1K claims, $1M revenue) ranks #199 of 2039 providers nationally (90th percentile; typical, unremarkable volume for this code). These ranks suggest a solid national presence for anti‑VEGF/anti‑angiogenic administration with above‑median activity on J2777 and a mid‑to‑upper decile position on J0178, but not dominance across the entire specialty.

Two utilization measures are statistical outliers nationally and point to unusually high diagnostic and office throughput: 92134 (2.8K claims, $102.5K revenue) ranks #502 of 26868 providers nationally (98th percentile; extreme outlier, far above typical national volume for this code), and 99213 (1.1K claims, $89.4K revenue) ranks #4898 of 457151 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code). High volume of retinal imaging and frequent established‑patient office visits imply a busy clinic workflow that likely supports frequent injection visits and monitoring.

The practice performs some surgical and procedure work beyond injections, though these codes contribute relatively small shares of Medicare revenue: examples include 66984 (141 claims, $65.8K revenue) and several vitrectomy/retinal repair codes (67036, 67108, 67113) appearing in the top 25 with modest revenue. This mix indicates the provider offers a continuum from in‑office injections and imaging to occasional cataract and retinal surgeries, but those surgical services are secondary to the pharmacologic treatment volume.

Provider tenure is long enough to indicate an established practice footprint: the NPI was enumerated 2009-07-09 (~17 years ago). Combined with the concentrated, repeatable revenue streams from intravitreal drugs and high imaging/visit volumes, this suggests a stable, mature retina practice rather than a new entrant.

Operational and payer implications: reliance on a small set of drug/office codes (top 3 = 74.4% of Medicare revenue) and the absence of Medicaid revenue mean the provider is exposed to changes in Medicare drug coverage, reimbursement policy, or utilization patterns without Medicaid diversification to offset shifts. For payers and network planners, these patterns flag a high‑volume injection/imaging site that could be important for managing retinal drug utilization and access, but that also carries concentrated revenue risk if utilization or coverage for the dominant codes changes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

32 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,520	$690	$1.1M
J2777	Injection, faricimab‑svoa, 0.1 mg	36,130	$30	$1M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,680	$120	$198K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,770	$40	$102.5K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,120	$80	$89.4K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	500	$160	$80.1K
J3490	Unclassified drugs	40	$1,650	$70.7K
66984	The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to…	140	$470	$65.8K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	500	$120	$59.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	450	$120	$54.2K

Showing 1–10 of 32

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 32 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New York Distribution

Chad Bouchard — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New York

Full comparison — all codes billed, vs. state median

32 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	54	230	560	$690	$693K
J2777	6	120	7,740	$30	$364.9K
J2778	69	70	510	$180	$131.6K
66984	228	680	90	$430	$104.3K
J2781	21	40	520	$120	$75.1K
67028	28	300	400	$100	$65.9K
J3490	73	120	60	$470	$50.8K
J7312	3	20	270	$160	$48K
92014	873	2,220	160	$100	$29.3K
67036	18	50	20	$940	$23.5K

Showing 1–10 of 32

Related Providers

Other providers that share a Tax Identification Number (TIN) with Chad Bouchard, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Albany Medical Center Hospital	NY	General Acute Care Hospital	$0	$79.8M
Alaska Retinal Consultants	AK	Ophthalmology Physician	$0	$4.5M
Scott Limstrom	AK	Ophthalmology Physician	$3.2M	$0
Matthew Guess	OH	Ophthalmology Physician	$2.8M	$0
Jonathan Huz	NY	Retina Specialist (Ophthalmology) Physician	$1.9M	$40.1K
George Lin	PA	Anatomic Pathology & Clinical Pathology Physician	$1.2M	$0
Ping Lu	NY	Nuclear Medicine Physician	$404.1K	$0
David Steckman	NY	Clinical Cardiac Electrophysiology Physician	$350K	$0
Shirish Parikh	NY	Diagnostic Radiology Physician	$298.7K	$1.1K
Sasi Cheruvu	NY	Diagnostic Radiology Physician	$241.7K	$590

Nearby Providers

Other providers in the same ZIP code as Chad Bouchard, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Naomi Falk	NY	Retina Specialist (Ophthalmology) Physician	$1.6M	$9.5K
Pawan Bhatnagar	NY	Retina Specialist (Ophthalmology) Physician	$1.5M	$16.4K
Sabah Shah	NY	Ophthalmology Physician	$1.3M	$35.5K
Robert Schultze	NY	Ophthalmology Physician	$253.2K	$0
George Soryal	NY	Nephrology Physician	$238.3K	$0
Matthew Habib	NY	Retina Specialist (Ophthalmology) Physician	$233.3K	$160
Robert Eden	NY	Specialist	$221.6K	$0
Edward Wladis	NY	Ophthalmic Plastic and Reconstructive Surgery Physician	$187.3K	$0
Michael Rothschild	NY	Ophthalmic Plastic and Reconstructive Surgery Physician	$106.1K	$0
David Foyt	NY	Otolaryngology Physician	$55.8K	$150

Chad Bouchard — Billing Profile & Reimbursement Data

Sign up for Chad Bouchard — Billing Profile & Reimbursement Data policy alerts

Chad Bouchard — Billing Profile & Reimbursement Data

Sign up for Chad Bouchard — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References